NASDAQ •
Healthcare •
Biotechnology •
Quote as of 06/18/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization566.68 mln
Float87.24 mln
Earnings Date08/06/2026
Piotroski F-Score
1
/ 9
Very weak
1-Year Forecast
13.11
Transformational upside
Relative Strength
17
/ 100
Significantly lagging
Debt / Equity
1.40
Elevated leverage
ROE
-221
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Achieve Life Sciences is a pharmaceutical company based in Bothell, Washington, focused on helping people quit smoking. Its lead product, cytisinicline, is a naturally derived compound that works by targeting nicotine receptors in the brain, easing the discomfort of withdrawal. The company operates across the United States, Canada, and the United Kingdom, supported by agreements with Sopharma AD and the University of Bristol for licensing and supply.
